Mandatory notice of trade in IDEX

IDEX ASA (“IDEX”) issues this notice on behalf of certain primary insiders in the company.

Board member Andrew James (Andy) MacLeod acquired 56,000 shares in the market on 15 September 2014, at an average price of NOK 4.48 per share. Following this transaction, Mr. MacLeod and his close relations hold or control 56,000 shares and 0 (nil) rights to shares in IDEX.

The board of directors of IDEX resolved on 15 September 2014 to grant 1,500,000 incentive subscription rights (“SRs”) to the CEO, Dr. Hemant Mardia, under the company’s 2014 incentive subscription rights plan as resolved at the annual general meeting on 7 May 2014. The exercise price of the SRs is NOK 4.45 per share. 25 % of the SRs vest on each anniversary from the date of the grant. The SRs expire on 7 May 2019. Following this transaction, Dr. Mardia and his close relations hold or control 265,625 shares and 7,000,000 incentive subscription rights in IDEX.

16 September 2014


Erling Svela, VP Finance,  +47 4062 1040,  erling.svela(at)

About IDEX
IDEX ASA specialises in fingerprint imaging and recognition technology. The company has a strong patent portfolio consisting of more than 20 patent families with more than 200 granted patents, and also a cross license with Apple. IDEX has a highly competitive product road map including swipe sensors, touch sensors with disruptive cost positions, and a unique in-glass solution. The company is currently in the process of commercialising the products.

IDEX’s addressable market represents a multi-billion unit opportunity, centred on three core markets: Mobile, ID & Smart Cards and the Internet of Things. IDEX has seen a substantial increase in interest from global OEMs in the last quarters, and is positioned as of three independent players with the relevant IP to capture market share. 

IDEX ASA (ticker IDEX) is a Norwegian public company listed at the Oslo Axess market place on the Oslo Børs (Oslo stock exchange). For more information, please visit or contact IDEX at


This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.